In conclusion, it was demonstrated that pro-oncogenic MZF1 and its potential antagonist SCAND1 coordinately regulate the expression of CDC37, a factor that is essential for prostate cancer tumorigenesis. Here, SCAND1 is linked to prostate carcinoma.